This study is currently recruiting participants.
To conduct a pilot study to identify potential serum biomarkers (DNA polymorphisms, circulating microRNA, white blood cell mRNA, nanoparticle proteomics) and link these with clinical phenotypes in a cohort of ocular myasthenia gravis (OMG) patients with precisely defined clinical characteristics.
Dr. Rudrani Banik, Neuro-Ophthalmologist
Katy Tai, Research Manager at 212-979-4251
Home > Current Research > Clinical Trials in Ophthalmology >Biomarker/Gene Expression Pilot Study on Ocular Myasthenia Gravis